HSCL2024-10-012024-12-31 HSCL2024-10-012024-12-31 HSCL2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member HSCL2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member HSCL2024-12-31 HSCL2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue01Member HSCL2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue02Member HSCL2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue01Member HSCL2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue02Member HSCL2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults01Member HSCL2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults02Member HSCL2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults01Member HSCL2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults02Member HSCL2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets01Member HSCL2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets02Member HSCL2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member HSCL2024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member HSCL2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member HSCL2024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member HSCL2024-10-012024-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member HSCL2024-10-012024-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member HSCL2024-10-012024-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member HSCL2024-10-012024-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member HSCL2024-10-012024-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member HSCL2024-10-012024-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500184 HSCL NA Himadri Speciality Chemical Limited Equity 2024-04-01 2025-03-31 2025-01-13 2025-01-06 INR Crores Third quarter 16:30:00 17:50:00 2025-01-13 2025-01-13 Not applicable Multi segment 2024-10-01 2024-12-31 Unaudited Consolidated 11406600000.00 119600000.00 11526200000.00 7805700000.00 0.00 -176300000.00 374300000.00 117600000.00 152200000.00 1194300000.00 9467800000.00 2058400000.00 0.00 2058400000.00 368100000.00 278800000.00 646900000.00 0.00 1411500000.00 0.00 0.00 0.00 0.00 1411500000.00 133800000.00 1545300000.00 1420600000.00 -9100000.00 1553500000.00 -8200000.00 493700000.00 1 2.88 2.85 0.00 0.00 2.88 2.85 1. The above unaudited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors in their respective meetings held on 13 January 2025. A Limited Review of these consolidated financial results for the quarter and nine months ended 31 December 2024 has been carried out by the Statutory Auditors, as required under Regulation 33 of SEBI (LODR) Regulations,2015. 2. Other expenses includes foreign exchange fluctuation loss/ (gain) (net) of Rs 4.03 crores for the quarter ended 31 December 2024, Rs (4.90) crores for the quarter ended 30 September 2024, Rs (3.71) crores for the quarter ended 31 December 2023, Rs (5.18) crores for the nine months ended 31 December 2024, Rs (9.03) crores for the nine months ended 31 December 2023 and Rs (9.68) crores for the year ended 31 March 2024. Finance cost includes exchange difference regarded as an adjustment to borrowing costs in accordance with Ind AS 23, of Rs 1.74 crores for the quarter ended 31 December 2024, Re 0.13 crore for the quarter ended 30 September 2024, Re 0.52 crore for the quarter ended 31 December 2023, Rs 1.87 crores for the nine months ended 31 December 2024, Rs 2.63 crores for the nine months ended 31 December 2023 and Rs 3.12 crores for the year ended 31.03.2024. 3. Based on the guiding principles given in Ind AS 108 on 'Operating Segments', the Group's business activity falls within two operating segments, namely: (a) Carbon materials and chemicals, and (b) Power 4.The consolidated financial results are prepared in accordance with the principles and procedures for the preparation and presentation of consolidated financial results as set out in Ind AS 110 'Consolidated Financial Statements' notified by Ministry of Corporate Affairs. The consolidated financial results of Himadri Speciality Chemical Limited (the Holding Company or the Parent), include its subsidiaries, namely AAT Global Limited, Shandong Dawn Himadri Chemical Industry Limited, Combe Projects Private Limited (w.e.f 20.07.2023), Himadri Clean Energy Limited (w.e.f 30 November 2023), Himadri Future Material Technology Limited (w.e.f 01 February 2024) and Himadri Green Technologies Innovation Limited (w.e.f 01 August 2024) (the Holding Company or the Parent and its subsidiaries together referred to as the 'Group'), combined on a line-by-line basis by adding together the book values of like items of asset and liabilities, income and expenses eliminating intra-group balances and transactions and resulting unrealised gains/ (losses). The Holding Company has acquired 40% paid-up share capital of M/s. Invati Creations Private Limited (ICPL) and this voting right does not qualify ICPL as a subsidiary under Section 2(87) of the Companies Act, 2013. However based on contractual rights (including potential voting right combined with 40% voting right), the Holding Company has the power to make decisions concerning relevant activities and thus has control over ICPL as per IND AS 110: Consolidated Financial Statements. Consequently, the management of the Holding Company has decided to consolidate the financial results of ICPL as a subsidiary with effect from May 17, 2024. The consolidated financial results are prepared applying uniform accounting policies on all material items. 5.During the quarter ended 30 June 2024, the Holding Company has issued and allotted 10,817,000 warrants, each convertible into one equity share of Re 1 each, on Preferential allotment basis at an issue price of Rs 316 per warrant, to the Promoters of the Holding Company and certain identified non-promoter persons, upon receipt of 25% of the issue price (i.e. Rs 79 per warrant) as warrant subscription money. Multi segment 2024-04-01 2024-12-31 Unaudited Consolidated 34779900000.00 381700000.00 35161600000.00 24396400000.00 0.00 -371700000.00 1037100000.00 360100000.00 412500000.00 3509000000.00 29343400000.00 5818200000.00 0.00 5818200000.00 1026500000.00 795400000.00 1821900000.00 0.00 3996300000.00 0.00 0.00 0.00 0.00 3996300000.00 213100000.00 4209400000.00 4000400000.00 -4100000.00 4213900000.00 -4500000.00 493700000.00 1 8.11 8.05 0.00 0.00 8.11 8.05 Other Expenses 1194300000.00 Other Expenses 3509000000.00 Carbon materials and chemicals 11345000000.00 Power 280500000.00 Carbon materials and chemicals 34603700000.00 Power 797500000.00 11625500000.00 35401200000.00 218900000.00 621300000.00 11406600000.00 34779900000.00 Carbon materials and chemicals 1844800000.00 Power 251900000.00 Carbon materials and chemicals 5034100000.00 Power 710700000.00 2096700000.00 5744800000.00 117600000.00 360100000.00 -79300000.00 Other unallocable expenses net of unallocable income includes other income and foreign exchange loss/ (gain) (net), fully unallocable Notes (contd.) 5. Contd... Balance 75% of the issue price (i.e. Rs 237 per warrant) shall be payable within 18 months from the date of allotment i.e.14 May 2024, at the time of exercising the option to apply for fully paid-up equity share of Re 1 each of the Holding Company, against each warrant held by the warrant holder. During the quarter ended 31 December 2024, the Holding Company upon receipt of balance 75% of the issue price (i.e., Rs 237 per warrant) for 25,000 warrants, has allotted equal no. of fully paid-up equity shares against conversion of said warrants exercised by the warrant holder. As a result of such allotment, the paid-up equity share capital of the Holding Company has increased from 493,656,224 equity shares to 493,681,224 equity shares of face value of Re 1 each. For the remaining 10,758,000 warrants, the respective allottees have not yet exercised their option for conversion of the warrants into equity shares and accordingly, balance 75% money towards such remaining warrants is yet to be received. The last day for exercising the option for conversion of the warrants into equity shares of the Holding Company is 13 November 2025, being 18 months from the date of allotment of warrants i.e., 14 May 2024. 6. The Holding Company on 17 May 2024, has acquired 40% paid-up equity share capital of Invati Creations Private Limited (“Target Company”), for a total purchase consideration of Rs 45.16 crores. The purchase consideration has been discharged in the following manner – i. Rs 19.99 crores has been paid in cash against fresh issue of 2,152 equity shares of Rs 10/- each constituting 17.71% stake, of the Target Company; and ii. Rs 25.17 crores payable for acquiring 2,709 equity shares of Rs 10 each, constituting 22.29% stake, of the Target Company from the existing shareholders of the Target Company for consideration other than cash has been settled by way of issue and allotment of 7,96,446 equity shares of the Holding Company having face value of Re 1/- each, at a price of Rs 316 per equity share (including a premium of Rs 315 (Rupees Three Hundred Fifteen only) per equity share to the existing shareholders of the Target Company. The acquisition was accounted for as a business combination using the acquisition method of accounting in accordance with Ind AS 103 ‘Business Combinations’. Pending final ascertainment of fair values of assets and liabilities acquired/assumed within a year from the date of acquisition (measurement period) the Holding Company has provisionally recognised intangible assets including goodwill. The Holding Company is in the process of ascertaining fair values of the assets acquired and liabilities assumed for the purpose of allocating the purchase price to Property Plant & Equipment and Intangible assets. The Holding Company expects to complete the purchase price allocation no later than one year from the acquisition date. 7. Pursuant to amendment in The Finance Act, 2024, resulting in withdrawal of indexation benefit on long term capital gain & consequential change in capital gain tax rate, the Holding Company has written back deferred tax liability amounting to Rs 13.81 crores. It has been recorded under tax expense under other comprehensive income in the consolidated financial results for the quarter and nine months ended 31 December 2024. 8. Earnings per share is not annualised for the quarter ended 31 December 2024, 30 September 2024, 31 December 2023, nine months ended 31 December 2024 and 31 December 2023. -433500000.00 2058400000.00 5818200000.00 Carbon materials and chemicals 32793300000.00 Power 1029300000.00 33822600000.00 13335300000.00 47157900000.00 Carbon materials and chemicals 3361400000.00 Power 5300000.00 3366700000.00 7642600000.00 11009300000.00 Remeasurement of the net defined benefit plan -500000.00 Net gain/(loss) on investment in equity instruments accounted at fair value -11100000.00 Remeasurement of the net defined benefit plan -1500000.00 Net gain/(loss) on investment in equity instruments accounted at fair value 50400000.00 -11600000.00 48900000.00 -139900000.00 -131100000.00 Exchange difference in transalating financial statements of foreign operations 5500000.00 Exchange difference in transalating financial statements of foreign operations 33100000.00 5500000.00 33100000.00 0.00 0.00